These highlights do not include all the information needed to use CAPECITABINE TABLETS safely and effectively. See full prescribing information for CAPECITABINE TABLETS. CAPECITABINE tablets, for oral use Initial U.S. Approval: 1998
National Dose Banding Table – Capecitabine
Capecitabine - wikidoc
Capecitabine - wikidoc
Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer
Xeloda Dosage Guide - Drugs.com
A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring--supporting patients in their homes - Document - Gale OneFile: Health and Medicine
PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar
Dose levels of capecitabine | Download Table
Daily Medication Pearl: Capecitabine (Xeloda)
N20-896S032 Capecitabine Clinical BPCA
Capecitabine dose calculation according to body surface area | Download Table
Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial | Anticancer Research
Capecitabine Tablets
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer – topic of research paper in Clinical
Approved for use in:
Capecitabine Teva Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
Capecitabine Acceptable in Neoadjuvant Rectal Cancer Setting - The ASCO Post
Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial - ScienceDirect
Seven-day capecitabine plus docetaxel and oxaliplatin regimen for the treatment of advanced gastric cancer: A phase-I clinical trial
Capecitabine Alvogen Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
XELODA Dosage & Rx Info | Uses, Side Effects
Cancers | Free Full-Text | Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214
Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy | PNAS